Corestreet Logo

Crispr Therapeutics AG (CRSP) Insider Trading

Total insider buys:
  • $79,647,674.22
Total insider sells:
  • $318,344,969.15
Most recent insider trade:
  • Feb. 19, 2026
Most active insider trader:
  • Samarth Kulkarni
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 16, 2018Insider66,000$28.03Sell$1,849,980.00
Jan. 5, 2018Major Shareholder527,472$22.75Buy$11,999,988.00
Jan. 5, 2018Director92,337$26.96Sell$2,489,405.52
Jan. 2, 2018Director37,754$26.76Sell$1,010,297.04
Jan. 2, 2018Insider38,000$21.64Sell$822,320.00
Dec. 29, 2017Insider31,000$22.72Sell$704,320.00
Dec. 28, 2017Insider700$21.75Sell$15,225.00
Dec. 22, 2017Director3,059$20.29Sell$62,067.11
Dec. 22, 2017Insider15,000$20.55Sell$308,250.00
Dec. 15, 2017Insider15,000$18.90Sell$283,500.00
Dec. 4, 2017Major Shareholder1,112,446$18.98Sell$21,114,225.08
Dec. 1, 2017Major Shareholder87,991$19.10Sell$1,680,628.10
Nov. 29, 2017Major Shareholder4,263$19.25Sell$82,062.75
Nov. 27, 2017Major Shareholder27,990$19.75Sell$552,802.50
Nov. 27, 2017Director200$20.24Sell$4,048.00
Nov. 24, 2017Major Shareholder26,010$20.00Sell$520,200.00
Nov. 24, 2017Director1,700$20.21Sell$34,357.00
Nov. 22, 2017Major Shareholder256,000$19.76Sell$5,058,560.00
Nov. 20, 2017Major Shareholder158,718$19.02Sell$3,018,816.36
Nov. 17, 2017Major Shareholder51,282$18.44Sell$945,640.08
Nov. 15, 2017Major Shareholder15,000$17.67Sell$265,050.00
Nov. 13, 2017Major Shareholder65,093$17.76Sell$1,156,051.68
Nov. 10, 2017Major Shareholder10,000$17.28Sell$172,800.00
Nov. 8, 2017Major Shareholder16,875$18.06Sell$304,762.50
Nov. 6, 2017Major Shareholder79,327$18.89Sell$1,498,487.03
Nov. 3, 2017Major Shareholder22,759$19.10Sell$434,696.90
Sept. 5, 2017CEO18,470$20.76Sell$383,437.20
Aug. 30, 2017CEO75,795$20.25Sell$1,534,848.75
Aug. 30, 2017Insider27,154$20.08Sell$545,252.32
Aug. 28, 2017Director88,011$19.79Sell$1,741,737.69
Aug. 25, 2017Director22,781$19.42Sell$442,407.02
Aug. 23, 2017Director17,989$18.53Sell$333,336.17
Aug. 21, 2017Director3,150$18.52Sell$58,338.00
Aug. 17, 2017Director34,141$19.06Sell$650,727.46
Aug. 15, 2017Director55,569$19.59Sell$1,088,596.71
Aug. 8, 2017Director35,473$18.63Sell$660,861.99
Aug. 8, 2017Insider15,000$18.57Sell$278,550.00
Aug. 4, 2017Director50,477$17.81Sell$898,995.37
Aug. 1, 2017Director5,512$17.51Sell$96,515.12
July 28, 2017Director41,312$17.63Sell$728,330.56
July 26, 2017Director32,930$17.60Sell$579,568.00
July 14, 2017Director69,859$16.84Sell$1,176,425.56
July 12, 2017Director31,992$16.56Sell$529,787.52
July 5, 2017Director4,254$16.26Sell$69,170.04
June 29, 2017Director43,202$16.90Sell$730,113.80
June 27, 2017Director81,435$17.08Sell$1,390,909.80
June 23, 2017Director32,368$16.23Sell$525,332.64
June 22, 2017CEO10,825$15.37Sell$166,380.25
June 21, 2017CEO30,222$15.01Sell$453,632.22
June 9, 2017CEO5,303$15.02Sell$79,651.06
First«3 of 4»Last

  • Insiders are both buying and selling Crispr Therapeutics AG stock.

  • The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, James R Kasinger, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, Vertex Pharmaceuticals (Europe, Michael John Tomsicek, Simeon George, Julianne Bruno, Naimish Patel, Bradley J. Phd Bolzon, James R. Kasinger, John Greene, Aktiengesellschaft Bayer, Raju Prasad, Tony W Ho, Tony W. Ho, and Versant Venture Capital V, L.P

  • The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 37 trades.

  • Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.

  • Simeon George has bought the most Crispr Therapeutics AG stock with a total value of $103,930,836.72.

  • The most recent insider trade for Crispr Therapeutics AG was on Feb. 19, 2026.

  • The single biggest insider buy for Crispr Therapeutics AG was from Simeon George with a total value of $51,499,918.36 on July 16, 2025.

  • The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.